Related Experiment Videos
Collagenolytic activity in hyperacute lung allograft rejection.
Pathology, Research and Practice
|January 1, 1980
Summary
Researchers identified collagenase activity in hyperacutely rejected lung transplants. This enzyme, likely from polymorphonuclear leukocytes, appears to mediate the immune response in lung graft rejection.
Area of Science:
- Immunology
- Transplantation Biology
- Biochemistry
Background:
- Hyperacute rejection is a rapid form of organ transplant failure.
- Collagenase enzymes play a role in tissue remodeling and degradation.
- Understanding the molecular mechanisms of rejection is crucial for improving transplant outcomes.
Purpose of the Study:
- To investigate the presence and origin of collagenase activity in hyperacutely rejected lung homotransplants.
- To determine the role of collagenase in the immunological rejection process of lung grafts.
Main Methods:
- Tissue explants from hyperacutely rejected canine lung grafts were analyzed for collagenase activity.
- Inhibition studies using EDTA, bacterial collagenase inhibitor, and normal serum were performed.
- Control experiments used lung tissue from untreated dogs.
Main Results:
- Collagenase activity was detected in all tested hyperacutely rejected lung graft specimens.
- The collagenolytic system was inhibited solely by EDTA, suggesting a metalloproteinase.
- Cysteine and normal serum did not inhibit the activity, ruling out bacterial collagenase or serum proteases.
- Inhibition studies indicated the enzyme originates from polymorphonuclear leukocyte lysosomes.
Conclusions:
- Collagenase activity is present in hyperacutely rejected lung homotransplants.
- The enzyme is likely of granulocytic (polymorphonuclear leukocyte) origin.
- Granulocytic collagenase appears to be a mediator in the immunological reaction leading to hyperacute lung graft rejection.